Drug Trial Radar · NCT02716246
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Apr 25, 2016
Primary completion
Mar 2029
Study completion Mar 2029
Sponsor
- Lead sponsor
- Ultragenyx Pharmaceutical IncIndustry
- Sponsor type
- Industry
- Collaborators
- Abeona Therapeutics, Inc
- First posted
- Mar 23, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this study is to evaluate the efficacy and safety of UX111 for the treatment of MPS IIIA.
Conditions
- MPS IIIA
- Sanfilippo Syndrome
- Sanfilippo A
- Mucopolysaccharidosis III
Interventions
UX111Biological
Self-complementary adeno-associated virus serotype 9 carrying the human SGSH gene under the control of a U1a promoter (scAAV9.U1a.hSGSH) will be delivered one time through a venous catheter inserted into a peripheral limb vein.
Prophylactic Immunomodulatory (IM) TherapyDrug
Optimized Prophylactic IM TherapyDrug
Adjuvant IM TherapyDrug
The Principal Investigator and/or caregiver, in consultation with the medical monitor, will determine whether to initiate adjuvant IM therapy. Not all participants may receive adjuvant IM therapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cerebrospinal Fluid (CSF) Heparan Sulfate (HS) (Disaccharide) ExposureTime frame: Up to Month 24 Visit
Locations
5 sites in 3 countries. Site status is shown where the registry gives one.
Nationwide Children's Hospital
Columbus, Ohio · Completed
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Completed
Women's and Children's Hospital
North Adelaide, South Australia, Australia · Completed
Hospital Clínico Universitario de Santiago
Santiago de Compostela, Spain · Recruiting
Vall d'Hebron Barcelona Hospital Campus
Barcelona, Barcelona, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.